Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · USD

$92.1

-1.43 (-1.5%)· Recorded snapshot

Market cap	5.5B
Revenue (ttm)	1.6B
Net income (ttm)	145.6M
EPS (ttm)	$2.43
Shares out	59.7M
P/E (trailing)	37.9x
P/E (forward)	21.2x
Volume	371,173
Beta	0.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.6B
Net income (ttm): 145.6M
EPS (ttm): $2.43
P/E (trailing): 37.9x
P/E (forward): 21.2x
Market cap: 5.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E21.2

P25 n/aP50 n/aP75 n/a

Trailing P/E37.9

P25 n/aP50 n/aP75 n/a

ROE9.2

P25 n/aP50 n/aP75 n/a

ROIC8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MMSI indicators

Market & fundamental data

Available fields

279

Groups with data

Currency

USD

Showing 279 of 279 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000856982
Company name	Merit Medical Systems, Inc.
Country	United States
Country code	US
CUSIP number	589889104
Earnings date	2026-10-29
Earnings time	amc
Employees	7,500
Employees change	100
Employees growth	1.35%
Enterprise value	$5.9B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1987
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
IPO date	1990-08-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US5898891040
Last 10-K release date	2026-02-24
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2011-05-06
Last stock split type	Forward
Market cap	$5.5B
Market cap category	Mid-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$92.10
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	MMSI
U.S. state	Utah
Website	https://www.merit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	22.52x
Average P/E ratio (10Y)	91.13x
Average P/E ratio (3Y)	42x
Average P/E ratio (5Y)	50.53x
Earnings yield	2.64%
EV/Earnings	40.49x
EV/EBIT	27.47x
EV/EBITDA	17.39x
EV/FCF	29x
EV/Sales	3.73x
FCF / EV yield	3.45%
FCF yield	3.68%
Forward EV/Sales	3.49x
Forward P/E	21.18x
Forward P/S	3.27x
Graham number	39.22443
Graham upside	-57.59%
Industry forward P/E	22.64x
Industry P/E	74.99x
Lynch fair value	$60.77
Lynch upside	-34.29%
P/(FCF - SBC) ratio	34.99x
P/(OCF - SBC) ratio	23.2x
P/B ratio	3.32x
P/E ratio	37.89x
P/FCF ratio	27.17x
P/OCF ratio	19.48x
P/S ratio	3.5x
PEG ratio	1.57x
Price / tangible book value	10.46x
Price/EBITDA ratio	16.29x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.59%
EBITDA margin	21.47%
Effective tax rate	25.15%
FCF margin	12.87%
Gross margin	49.51%
Operating margin	13.59%
Pretax margin	12.32%
Profit margin	9.22%
Profit per employee	$19,408
Profitable quarters	23
Profitable years	5
Revenue per employee	$210,508
ROA	4.92%
ROA (5Y)	4.14%
ROCE	8.26%
ROE	9.19%
ROE (5Y)	7.54%
ROIC	8.01%
ROIC (5Y)	7.41%
SBC / revenue	2.87%
Tax / revenue	3.1%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	23.23%
EPS growth (Q)	20.37%
EPS growth (QoQ)	-4.41%
EPS growth 10Y	16.9%
EPS growth 3Y	16.47%
EPS growth 5Y	37.22%
EPS growth quarters	3
EPS growth years	5
FCF growth	5.66%
FCF growth (Q)	-25.32%
FCF growth (QoQ)	110.54%
FCF growth 3Y	61.21%
FCF growth 5Y	8.44%
Gross profit growth	13.78%
Gross profit growth (Q)	16.63%
Gross profit growth 3Y	12.14%
Gross profit growth 5Y	11.72%
Net income growth	22.2%
Net income growth (Q)	19.1%
Net income growth (QoQ)	-5.35%
Net income growth 3Y	17.55%
Net income growth 5Y	38.81%
Net income growth quarters	3
Net income growth years	5
OCF growth	18.13%
OCF growth (Q)	-16.84%
OCF growth (QoQ)	70.29%
OCF growth 10Y	17.92%
OCF growth 3Y	43.8%
OCF growth 5Y	10.96%
Operating income growth	20.77%
Operating income growth (Q)	28.76%
Operating income growth 3Y	24.91%
Operating income growth 5Y	29.13%
Revenue growth	10.19%
Revenue growth (Q)	9.51%
Revenue growth (QoQ)	9.68%
Revenue growth 10Y	10.93%
Revenue growth 3Y	9.63%
Revenue growth 5Y	8.89%
Revenue growth quarters	24
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-80.2M
Depreciation and amortization	$124.4M
EBIT	$214.6M
EBITDA	$338.9M
EPS	$2.43
FCF per share	$3.40
Financing cash flow	$-644,000
Free cash flow	$203.2M
Free cash flow minus SBC	$157.8M
Gross profit	$781.7M
Income taxes	$48.9M
Investing cash flow	$-176.8M
Net cash flow	$107M
Net income	$145.6M
Operating cash flow minus SBC	$238.1M
Operating income	$214.6M
Revenue	$1.6B
Stock-based compensation	$45.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.98
Book value per share	$28.13
Debt / EBITDA	2.3
Debt / equity	0.49
Debt / FCF	4.04
Goodwill	$539.8M
Interest coverage	6.75
Long-term assets	$1.8B
Long-term liabilities	$918.9M
Net cash (debt)	$-371.4M
Net cash / market cap	-6.73%
Net debt / EBITDA	1.1
Net debt / equity	0.22
Net debt / FCF	1.83
Piotroski F-Score	7
Property, plant and equipment	$520.5M
Shareholders' equity	$1.7B
Tangible book value	$528M
Tangible book value per share	$8.84
Total assets	$2.9B
Total cash	$448.7M
Total debt	$820.1M
Total liabilities	$1.2B
WACC	6.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	$1.1B
Current liabilities	$264.9M
Current ratio	4.2
Inventory turnover	2.29
Net working capital	$409.5M
Quick ratio	2.64
Working capital	$847.3M
Working capital turnover	2.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.86%
Dividend yield	0%
Shareholder yield	0.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	321.23%
10Y return CAGR	15.47%
10Y total return	321.23%
150-day SMA	$76.71
15Y price change	559.02%
15Y return CAGR	13.39%
15Y total return	559.02%
1D price change	-1.53%
1M price change	5.67%
1M total return	5.67%
1W price change	1.4%
1W total return	1.4%
1Y price change	11.73%
1Y return CAGR	11.74%
1Y total return	11.73%
20-day SMA	$89.25
200-day SMA	$76.86
20Y price change	627.8%
20Y return CAGR	10.43%
20Y total return	627.8%
3M price change	21.5%
3M total return	21.5%
3Y price change	34%
3Y return CAGR	10.25%
3Y total return	34%
50-day SMA	$88.66
50-day SMA vs 200-day SMA	50over200
52-week high	$94.85
52-week high date	2026-10-26
52-week low	$59.74
52-week low date	2026-05-12
5Y price change	35.02%
5Y return CAGR	6.19%
5Y total return	35.02%
6M price change	37.12%
6M total return	37.12%
All-time high	$111.45
All-time high date	2025-01-31
All-time low	$1.09
All-time low date	2000-05-10
Average true range (ATR)	$2.13
Average volume	636.5K
Beta (1Y)	0.29
Beta (2Y)	0.62
Beta (5Y)	0.51
Change from 52-week high	-2.9%
Change from 52-week low	54.17%
Change from all-time high	-17.04%
Change from all-time low	8,390.36%
Change from open	-0.77%
Day's gap	-0.77%
Dollar volume	$34.2M
High price	$93.13
Low price	$92.08
Monthly RSI	56.42
Open price	$92.81
Position in 52-week range	1.9%
Premarket change	-0.03%
Premarket close	$93.53
Premarket price	$93.50
Premarket volume	862
Previous close	$93.53
Price vs 150-day SMA	20.54%
Price vs 20-day SMA	3.6%
Price vs 200-day SMA	20.3%
Price vs 50-day SMA	4.29%
Relative volume	0.58
RSI	60.42
Sharpe ratio	0.39
Sharpe ratio (3Y)	0.42
Sharpe ratio (5Y)	0.2
Sortino ratio	0.75
Sortino ratio (3Y)	0.79
Sortino ratio (5Y)	0.47
Volume	371.2K
Weekly RSI	66.23
YTD price change	4.9%
YTD total return	4.9%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.3M
Float percentage	97.64%
Shares change (QoQ)	-0.01%
Shares change (YoY)	-0.86%
Shares held by insiders	2.31%
Shares held by institutions	106.5%
Shares outstanding	59.7M
Short % of float	6.23%
Short % of shares	6.08%
Short ratio	5.9 days

Deeper analysis on MMSI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MMSI report

Is a complete MMSI research report available?

No complete published report is available for Merit Medical Systems, Inc. (MMSI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Merit Medical Systems, Inc. (MMSI)

Price

Financial snapshot

Fair-value bridge

Latest news · MMSI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MMSI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MMSI

Frequently asked questions